Patrick O’Connor, MD, MPH

Patrick G. O’Connor, MD, MPH, MACP, is the Dan Adams and Amanda Adams Professor of Medicine and Chief of General Internal Medicine at Yale.   In this role, he has recruited leading physician-scientists whose research focuses on critical topics such as addiction medicine, cancer, cardiovascular disease, HIV, stroke, health disparities, health justice, health policy, bioethics, occupational medicine, medical education, and the humanities in medicine. His faculty have also developed and led several innovative clinical and educational programs and provide state-of-the-art education for trainees at all levels.

Dr. O’Connor’s research has focused on the interface between GIM and addiction medicine.  He has written over 200 scientific papers, and his work has been published in leading journals including NEJM, JAMA, and JGIM. Among these publications is the first RCT of buprenorphine for treating opioid use disorder in primary care. He also served as an author on the 2016 Surgeon General’s Report.  He has collaborated with federal agencies, including the White House Office on National Drug Control Policy.  He is a Co-PI on two NIDA-funded career development programs: Drug use, Addiction, and HIV Research Scholars (DAHRS), and The Research in Addiction Medicine Scholars (RAMS).

Dr. O’Connor has served as SGIM Treasurer and as New England Region President.  He is also past president of the American Board of Addiction Medicine (ABAM) and the Association for Multidisciplinary Research and Education in Substance Use and Addiction (AMERSA). He received “Excellence in Mentorship Award” from AMERSA in 2005 and the Chief’s Recognition Award from SGIM/ACLGIM in 2007. He also received the McGovern Award from AMERSA in 2017 and the Glaser Award from SGIM in 2019.  He was elected to Mastership in the ACP and to membership in the Association of American Physicians in 2022.   He serves as the Chair of the Board of the National Clinician Scholars Program.